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Abstract
Rift valley fever virus (RVFV) infection is an emerging zoonotic disease endemic in many countries of sub-Saharan Africa and
in Egypt. In this study we show that human small airway epithelial cells are highly susceptible to RVFV virulent strain ZH-501
and the attenuated strain MP-12. We used the reverse-phase protein arrays technology to identify phosphoprotein signaling
pathways modulated during infection of cultured airway epithelium. ZH-501 infection induced activation of MAP kinases
(p38, JNK and ERK) and downstream transcriptional factors [STAT1 (Y701), ATF2 (T69/71), MSK1 (S360) and CREB (S133)]. NF-
kB phosphorylation was also increased. Activation of p53 (S15, S46) correlated with the increased levels of cleaved effector
caspase-3, -6 and -7, indicating activation of the extrinsic apoptotic pathway. RVFV infection downregulated
phosphorylation of a major anti-apoptotic regulator of survival pathways, AKT (S473), along with phosphorylation of
FOX 01/03 (T24/31) which controls cell cycle arrest downstream from AKT. Consistent with this, the level of apoptosis
inhibitor XIAP was decreased. However, the intrinsic apoptotic pathway marker, caspase-9, demonstrated only a marginal
activation accompanied by an increased level of the inhibitor of apoptosome formation, HSP27. Concentration of the
autophagy marker, LC3B, which often accompanies the pro-survival signaling, was decreased. Cumulatively, our analysis of
RVFV infection in lung epithelium indicated a viral strategy directed toward the control of cell apoptosis through a number
of transcriptional factors. Analyses of MP-12 titers in challenged cells in the presence of MAPK inhibitors indicated that
activation of p38 represents a protective cell response while ERK activation controls viral replication.
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Introduction
Rift Valley fever virus (RVFV) is a highly-pathogenic arthro-
pod-borne Phlebovirus of the Bunyaviridae family that infects a wide
range of vertebrate hosts. In humans RVFV infection can lead to
encephalitis, retinitis, or fatal hepatitis associated with hemor-
rhagic fevers. In ruminants it is associated with high mortality
rates, abortion, and fetal deformities [1,2]. RVFV infection is an
emerging zoonotic disease endemic in many countries of sub-
Saharan Africa and in Egypt. During the last decade the number
of devastating outbreaks increased progressively [3,4]. Although
the major route of RVFV entry into the host is through mosquito
bites, some evidence indicates that aerosol route of infection can
be highly effective. Laboratory workers have acquired RVFV
supposedly after inhalation of infectious aerosols generated by
careless handling of infected tissues [5]. Also, several animal
species have been shown experimentally to be highly susceptible to
airborne RVFV [5,6]. From this point of view, RVFV is
considered as a potential biothreat. However, the frequency of
airborne RVFV transmission under natural conditions remains
unknown and interaction of the virus with the potential cell targets
in the respiratory tract has not been studied.
The information on the molecular biology of RVFV and its
interaction with host cells is limited. RVFV has a tripartite single-
stranded RNA genome consisting of large (L), medium (M), and
small (S) segments [7]. The L and M segments are of negative
polarity and express, respectively, the RNA-dependent RNA
polymerase L and the precursors to the glycoproteins Gn and Gc.
Gn and Gc cleavage also generates a nonstructural protein (NSm)
that has been recently identified as a suppressor of virus-induced
apoptosis [8]. The S segment utilizes an ambisense strategy and
encodes the nonstructural protein NSs in genome orientation and
the nucleoprotein N in antigenome orientation. RVFV NSs
protein is not essential for virus replication in cell culture [9], while
it works as a major viral virulence factor in infected animals [10].
NSs is expressed early in virus infection prior to viral RNA
replication. It inhibits the induction of interferon beta [11],
suppresses the host innate immune system by downregulation of
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eIF2-alpha phosphorylation [12], along with the general inhibition
of cellular transcription [13].
Phosphorylation plays a key role in regulating many signaling
pathways. Cell fate decisions in response to extracellular agents,
including pathogenic invaders, are commonly mediated by
phosphorylation-regulated signaling cascades that transduce
signals into stimulus-specific actions, such as changes in gene
expression pattern. Generally, both proapoptotic and prosurvival
pathways are activated during viral replication. The possibility to
interfere with virus replication either by enhancing antiviral
signaling or by inhibiting proviral signaling can open a new
avenue to antiviral treatments and prophylaxes. For example, in
the proof-of-concept studies the inhibitors of Raf/MEK/ERK
mitogenic kinase cascade and the IKK/NF-kB module reduce
influenza virus titer in the lungs of infected mice after local aerosol
administration into the trachea [reviewed in 14]. However, in the
case of RVFV this potential opportunity has not been previously
explored because of the limited knowledge of the intracellular
events during infection. We therefore characterized the phospho-
protein signaling by RVFV in the human small airway lung
epithelial cells (HSAECs) as an in vitro model relevant to aerosol
exposure. Using a high-throughput reverse-phase phosphopro-
teome analysis during the time course of infection of HSAECs with
the virulent wild-type RVFV strain ZH-501 we identified changes
in major prosurvival and proapoptotic pathways controlled by the
virus. Our analyses suggest a number of phosphoproteins as
potential points of pharmacological interventions.
Materials and Methods
Reagents
The ZH-501 strain of RVFV was isolated in 1977 from the blood
of a 10-year-old Egyptian girl, who had a fatal RVFV infection[15].
This strain was passed twice in fetal rhesus monkey lung cells and
once in Vero (African green monkey kidney) cells before use in this
study. The attenuated RVFV MP-12 strain was a kind gift from Dr.
Sina Bavari, United States Army Medical Research Institute of
Infectious Diseases. The RVFV MP-12 was propagated and titrated
using Vero cells. Experiments with live ZH-501 virus were carried
out in the BSL-3 containment lab at the Virology Division of the
United States Army Medical Research Institute of Infectious
Diseases, MD, USA. Experiments with the MP-12 strain were
carried out in the BSL-2 environment at the Biomedical Research
Laboratory, George Mason University, Manassas, VA.
Cell culture reagents were from CellGro (Herndon, VA).
Antibodies against total and phosphorylated forms of the following
proteins used for reverse-phase protein microarrays (RPMA) and
Western blots were from Cell Signaling Technology (Beverly, MA)
and were used at the dilutions indicated: 1:2000 for ERK1/2
(T202/Y204), 1:200 for STAT1 (Y701), 1:50 for Caspase-3 cleaved
(D175), 1:100 for Caspase-7 cleaved (D198), 1:50 for Caspase-6
cleaved (D162), 1:1000 for p53 (S46), 1:50 for SAPK/JNK (T183/
Y185), 1:1000 for p53 (S15), 1:200 for p90RSK (S380), 1:100 for
HSP27, 1:50 for MSK1 (S360), 1:50 for p38 (T180/Y182), 1:500
for MEK1/2 (S217/221), 1:100 for STAT3 (S727), 1:100 for ATF-
2 (T69/71), 1:50 for NF-kappaB p65 (S536), 1:400 for CREB
(S133), for IRS-1 (S612), 1:1000 for Puma, 1:250 for FOX 01/03a
(T24/32), 1:250 for Src (Y527), 1:1000 for Bim, 1:100 for Akt
(S473), 1:100 for XIAP, 1:100 for LC3B, 1:50 for Cyclin D1, 1:100
for FADD (S194), 1:250 for GSK-3 alpha/beta (S21/9), 1:500 for
PKR (T451), 1:50 for Beclin-1, 1:100 for mTOR (S2481), 1:500 for
PTEN (S380), 1:100 for total p38, 1:50 for p70S6 Kinase (S371),
1:50 for AMPKalpha1 (S485), 1:500 for Bax, 1:100 for Bad (S136),
1:100 for Elk1 (S383), 1:1000 for Bid, 1:500 for total SAPK/JNK,
1:200forc-Raf(S338),1:100 forcaspase-9cleaved(D315); 1:100for
caspase-9 cleaved (D330), 1:500 for Atg 5, 1:50 for FAK (Y397),
1:500 for PP2A A Subunit, 1:100 for ASK1 (S83), 1:200 for eNOS
(S1177), 1:50 for b-Raf (S445), 1:200 for HSP90 (E289), 1:100 for
total AKT, 1:1000 for total ERK1/2, 1:100 for Bcl-2 (T56), 1:100
for p27(T187),1:100 for Src family (Y416), 1:200 for beta actin,
1:100 for total p53, 1:100 for Jak1 (Y1022/1023), 1:50 for HSP70,
1:1000 for total PKR. The secondary HRP-labeled goat anti-rabbit
antibody was from Cell Signaling Technology (Beverly, MA) and
was used at the dilution 1:10000 for Western blot. The antibody
against the viral antigen was from ProSci, Inc. (Poway, CA). It was
raised against a peptidecorrespondingto a fragment near the center
of the protein precursor translated from the M segment. It therefore
detects both the precursor and the glycoprotein G1.
Challenge of HSAECs with RVFV
HSAECs (Cambrex Inc., Walkersville, MD) from anonymous
donor were grown according to the vendor’s protocol in Ham’s F12
medium supplemented with nonessential amino acids, pyruvate, b-
mercaptoethanol and 10% fetal calf serum (FCS) at 37uC, 5% CO2.
The cells were adapted to these culture conditions during four
passages and then were used for the preparation of the frozen stock.
For reverse phase protein (RPMA) microarray experiments,
confluent HSAECs at 10
6 cells per well in 6-well plates were
challenged with RVFV ZH-501 at the multiplicity of infection
(MOI) of 0.0002 and 0.002.100 ml of RVFVsuspension in a diluent
(10% heat-inactivated FBS in Medium 199 with Earle’s salts,
NaHC03 and antibiotics) containing 10
3.3 and 10
2.3 PFU of RVFV
(MOI of 0.002 and 0.0002, correspondingly) or diluent were added
to each well. Cells were incubated for 1 h at 37uC in the CO2
incubator and then 3 ml of HSAECs medium were added to each
well and the plates returned to the CO2 incubator. At 0, 5, 24, 30,
48, 72 h post virus infection (h.p.i.), supernatant was removed, the
cells were mixed with 500 ml of the lysis buffer, and immediately
boiled for 10 min. The lysis buffer consisted of 1:1 mixture of T-
PER Reagent (Pierce, IL) and 26Tris-glycine SDS sample buffer
(Novex, Invitrogen, CA) in the presence of 2.5% b -mercaptoeth-
anol, and protease and phosphatase inhibitors (16 Halt cocktail,
Pierce). Lysed samples were stored at 280uC. Three independent
cell challenge experiments were performed for the RPMA and
Western blot analyses.
RPMA and Western blot analyses
Approximately 30 nl of each sample (equivalent to the amount of
material from 40 lysed cells) were arrayed onto nitrocellulose slides
(Whatman, MA) by direct contact printing using a high-resolution
2470 arrayer (Aushon Biosystems, Billerica, MA). Samples were
printed as duplicates of an eight-point two-fold dilution series. The
linear range of each dilution curve was then used for quantitative
data comparisons between samples. Slides were stored at 220uC
prior to detection. To estimate the total protein amount in each
spot, several randomly selected slides were stained with Sypro Ruby
Protein Blot Stain (Molecular Probes, Eugene, OR) and visualized
on a Fluorchem imaging system (Alpha Innotech, San Leandro,
CA). Slides were stained on a Dako Autostainer with specific
antibodies using a biotin-linked peroxidase-catalyzed signal ampli-
fication (Dako, CSA kit). Specifically, the arrayed slides were placed
into Re-Blot solution (Chemicon, Temecula, CA) for 15 min,
washed two times for 5 min each in PBS, placed into I-Block
solution (Applied Biosystems, Foster City, CA) in PBS with 0.1%
Tween-20 for at least 2 h, and then immunostained using an
automatic slide stainer (Autostainer, Dako Cytomation) and the
manufacturer-supplied reagents. Briefly, the slides were incubated
RVFV Cell Signaling
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buffered saline (CSA Buffer, Dako) supplemented with 0.1%
Tween-20, blocked with avidin block solution for 10 min, rinsed
with CSA buffer, and then incubated with biotin block solution for
10 min. After another CSA buffer rinse, 5-min incubation with
protein block solution was followed by air drying. the slides were
incubated with either a specific primary antibody diluted in Dako
Antibody Diluent or, as a control, with only Dako Antibody Diluent
for 30 min. Every antibody underwent extensive validation
ensuring a specific detection of the antigenic protein as a single
band on the Western blot of cell lysate. The slides were washed with
CSA buffer and incubated with a secondary biotinylated goat anti-
rabbit IgG H1L antibody (1:7500) (Vector Labs, Burlingame, CA)
for 15 min. Slides were incubated with diaminobenzidine chromo-
gen diluted in Dako diaminobenzidine diluent for 5 min, washed in
deionized water and imaged using a Umax PowerLook III scanner
(Umax, Dallas, TX) at 600 dpi. The images were analyzed with
software AlphaAse FC (Alpha Innotech). For each antibody, the
average pixel intensity value for negative control (staining with
second antibody only) was subtracted from the average pixel
intensity value for specific antibody and then normalized by the
corresponding average value of the total protein intensity. Each
sampledilutioncurve ineachexperiment wasfittedwitha nonlinear
approximation equation and statistically evaluated using GraphPad
Prism ver5 software (Graphpad Software, CA). The dilution of
differentsampleschosenwithinthelinearresponseintervalwasused
to calculate relative analyte concentrations and their 95%-
confidence intervals. The RPMA experiments were repeated 3
times to ensure consistent results.
Signaling proteins demonstrating differences between control
and challenged cells were further tested with Western blots using
15 ml of cell lysates, 1:1000-diluted primary antibodies, and
1:10000-diluted secondary antibody (goat anti-rabbit). Proteins
were transferred to a nitrocellulose membrane using iBlot Gel
Transfer Device (Invitrogen). The membranes were developed with
SuperSignal West Femto Maximum Sensitivity Substrate (Pierce),
and band intensities were measured with a Molecular Imager
ChemiDoc XRS System (Bio-Rad, CA). The intensities of bands
were calculated relative to untreated controls after densitometry
using the QuantityOne 4.6.5 program (Bio-Rad). All measurements
were performed in triplicate. Data are represented as mean values
with 95%-confidence intervals (two-tail t-test, a=0.05, n=3).
MP-12 infection and inhibitor studies
For Western blot analyses, HSAECs were grown in HAM’s F-
12 medium for 100% confluence in 12 well plates. Next day after
confluency the cells were rinsed with PBS twice and challenged at
MOIs of 0.002 and 2 at 37uC, 5% CO2 for 1 h with 400 ml RVFV
MP-12 propagated and titrated using the Vero cells. After 1 h the
virus was removed, cells were rinsed with PBS twice and 1 ml of
HAM’s F-12 medium was added to each well. The infected cells
were incubated at 37uC, 5% CO2 for 24, 48 and 72 h. After each
time point the cells were rinsed with PBS twice, lysed in 250 mlo f
lysis buffer used in the RPMA experiments, and boiled for 10 min.
For the inhibitor studies, HSAECs were seeded at 50,000 cells
per well in a 96-well plate. The inhibitors (from Calbiochem) were
dissolved in DMSO and added to the cells for 5 h prior to
infection. A DMSO-only control was included and the final
concentration of DMSO was 0.1%. Final concentrations of
inhibitors were: 1 mM for p38 inhibitor SB203580, 10 mM for
JNK inhibitor II and 10 mM for MEK1/2 Inhibitor III. The latter
is known to specifically inhibit phosphorylation of ERK1/2.
Medium was removed and cells were infected with RVFV MP-12
at MOI of 0.002 in 25 ml of medium. After one hour of infection,
fresh medium containing inhibitors was added to cells. Superna-
tants were collected at 48 h.p.i., viral RNA extracted using
Ambion’s MagMAX
TM-96 Viral RNA Isolation Kit, and RNA
analyzed by q-RT-PCR. RVFV q-RT-PCR assays were per-
formed with a titration of purified viral RNA to establish a
standard curve. The primers and probe used were originally
described by Drosten et al. [1]. Assay conditions were as follows:
0.4 mM primers, 0.5 mM FAM-probe, 1 mM additional MgSO4,
0.4 ml Rox reference dye, 1.0 ml RNA UltraSense
TM Enzyme Mix,
4.0 ml RNA UltraSense
TM 56 Reaction Mix. Reactions were
performed in a 20 ml volume using an ABI 7000 Real Time PCR
instrument. Cycling conditions were 50uC for 15 min, 95uC for
2 min, followed by 40 cycles of 95uC for 15 s and 60uC for 30 s.
Results
RVFV infection has a profound influence on
phosphoprotein signaling in HSAECs
To study host cell signaling by protein phosphorylation during
RVFV infection, we used a model of HSAECs challenged with the
virulent strain of RVFV (ZH-501). We hypothesized that this model
would faithfully reflect signaling induced by inhaled RVFV in the
infected lung epithelium. HSAECs were grown to confluency in 6-
well plates. One day later the cells were infected with the virus at
MOIs of 0.0002 and 0.002. The MOIs were chosen to avoid rapid
apoptosis of cells and resemble the low-dose in vivo infection by
mosquito bites or inhalation. RVFV was able to cause a productive
infection of HSAECs as detected by a progressive cytopathic effect
upon visual examination of cell monolayer morphology at different
times post infection (data not shown). Cytopathic effect (rounding up
and dislodging ofcells from theplastic substrate)was first observed at
72 h. Quantitative analysis of the newly-formed virus released from
HSAECs into culture supernatants was performed by plaque assay
(Fig. 1a). In addition, the levels of intracellular virus antigen during
the period from 5 to 72 h post infection (h.p.i.) were tested by
Western blot of cell lysates using antibody specific to the viral
proteinsGc,GnandNSm (Fig.1b,c).Concentration ofviralantigen
reached maximum at 48 and 72 h.p.i. (for MOI of 0.002 and
0.0002, respectively). Collectively these results indicate that active
infection was observed in primary lung epithelial cells at both MOIs.
For phosphoproteomic analysis the cell lysates were printed onto
nitrocellulose membrane slides. Each slide was then probed with
one of 60 different antibodies specific against phosphorylated or
total forms of signaling proteins. The antibodies were selected to
monitor the molecular networks involved in host responses most
likely affected by virus exposure, namely survival, apoptosis,
inflammation, growth, differentiation, and immune response. This
RPMA technique was extensively validated in our previous studies
[16] with regardto specificityofantibodies, sensitivity,andaccuracy
of phosphoprotein detection in cell lysates. As an example, slides
stained with antibody against total and phosphorylated form of
SAP/JNK, ERK and AKT and against phosphorylated form of p-
38 and PTEN are shown in Fig. 2. All samples for untreated and
RVFV-infected HSAECsfrom differenttime pointswereprinted on
the same slide. Boxed dots show untreated and RVFV-infected
HSAECs at 48 and 72 h.p.i. at MOI of 0.002 (high) and MOI of
0.0002 (low). Significant changes are seen in the levels of
phosphorylated forms of SAP/JNK, p38, ERK and AKT for
RVFV-infected cells in comparison with untreated cells, whereas
total forms of these proteins demonstrate only subtle changes.
PTEN illustrates the protein which phosphorylation was not
affected by RVFV infection.
In order to carry out quantitative analyses of RPMA data, the
average total level of cellular protein at every time point was
RVFV Cell Signaling
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randomly selected slides throughout the print run (Fig. 3). Similar
levels of total protein were detected in infected and uninfected cells
at the same time points post infection, likely reflecting cell growth
without a detectable lysis up to 48 h.p.i. However, due to the
progressive cytopathic effect of the virus, cell lysis became evident
at 72 h.p.i. Since the RPMA analysis reflects the levels of
intracellular proteins, all data were normalized to the total level
of cellular proteins. The normalized values allowed direct
comparison of results during the time course of infection.
Of the 60 tested signaling proteins, the relative levels of 27
phosphorylated proteins and activated protein forms (such as
cleaved caspases) showed statistically significant (p,0.05) differ-
ences compared to uninfected cells at 48 and 72 h.p.i. (Table 1).
Earlier time points did not demonstrate statistically significant
differences between uninfected and RVFV-infected HSAECs.
During the next 24 h the concentration of released virus increased
more then 100-fold and was accompanied by a strong amplifica-
tion of the phosphoprotein response. In order to validate the
RPMA data, the levels of eight selected proteins were analyzed by
Western blots using antibodies against phosphorylated and total
forms of proteins (Fig. 4). Average band intensities from two
independent Western blot experiments normalized to the total
amount of cellular protein demonstrated good agreement with the
data obtained from three independent RPMA experiments (Fig. 5).
All 27 signaling proteins can be divided into three groups
according to similarities in their temporal phosphorylation
patterns (Table 1). In the first group the phosphorylation of the
mitogen-activated protein kinase ERK1/2 and transcription factor
STAT1, which is activated through a p38 (mitogen-activated
protein kinase) MAPK-dependent pathway in response to IFN-a
and other cellular stresses, were constantly increased. The same
pattern was demonstrated by the cleaved caspases-3, -6 and -7,
which are major components of extrinsic and intrinsic apoptotic
pathways. The second group includes 13 proteins comprising the
transcription factors: p53 (S15 and S46) controlling cell cycle
arrest, DNA repair or apoptosis; MSK-1 (S360) activated by ERK
and p38; anti-apoptotic STAT3 (S727) activated through the
MAPK or mTOR pathways; ATF2 (T69/71) activated by SAPK/
JNK and p38 MAPK; NF-kB p65 (S536) playing a pivotal role in
inflammatory and immune responses; and CREB (S133) mediat-
ing numerous cellular responses. Among Group II are kinases
SAP/JNK (T183/Y185) and p38 (T180), which regulate various
cellular activities such as gene expression, mitosis, differentiation,
proliferation, and cell survival/apoptosis; MAPK kinase MEK1/2
(S217/221); the 90 kDa ribosomal S6 kinase, p90RSK (S380),
which is activated via coordinated phosphorylation by MAPKs,
phosphoinositide-3-OH kinase (PI3K) and autophosphorylation in
response to many growth factors, polypeptide hormones and
neurotransmitters; insulin receptor substrate IRS-1 (S612), which
phosphorylation is necessary for activation of AKT; and HSP27,
conferring cellular resistance to adverse environmental changes.
For group II, protein phosphorylation demonstrated a transient
pattern of initial increase followed by a decline detectable mostly
at the MOI of 0.002. However, at lower MOI of 0.0002, no
decline of phosphorylation took place for the majority of these 13
Figure 1. Quantitative analysis of the newly-formed virus released from HSAECs into culture supernatants. A. Plaque assay data are
presented as lg (PFU/ml) in supernatants of RVFV-infected HSAECs for MOI of 0.002. B, C. Western blot of lysed cells using antibodies against peptide
from the middle of RVFV M segment and against actin (B, for MOI of 0.002 and C, for MOI of 0.0002). The amount of cells loaded was 1.4610
4 cells per
well. Band intensities (arbitrary units) of viral proteins above the background detected in uninfected cells are shown as graphs below of Western data.
The positions of Gc, Gn and NSm proteins translated from the M-segment are shown with arrows.
doi:10.1371/journal.pone.0013805.g001
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compared to the higher MOI.
The third group of 7 proteins includes several protein kinases.
Among them are serine/threonine kinase AKT (protein kinase B),
the global regulator of survival; protein kinase R (PKR), which
mediates apoptosis induced by viral double-stranded RNA
(dsRNA); and the protein tyrosine kinase c-Src, which activity is
regulated by tyrosine phosphorylation at two sites Y416 and Y527,
but with opposite effects. Group III also includes apoptosis
inhibitor XIAP. In this group the phosphorylation levels showed a
statistically significant, continuous decrease during the infection.
The same pattern of continuous decrease was demonstrated for
the total level of autophagic protein LC3B, and the pro-apoptotic
proteins Bim and Puma belonging to the Bcl-2 family.
Analysis of pro-apoptotic signaling and caspase
activation
Modulation of apoptosis is a known feature of RVFV [8].
Therefore, along with protein phosphorylation events we analyzed
the levels of cleaved caspases. As indicated above, HSAECs
infected with RVFV demonstrated increased levels of cleaved
effector caspase-3, -6 and -7 at both MOIs; however, the level of
caspase-9 cleaved at the activation sites D315 and D330 did not
change significantly at both tested MOIs (Table 1, Fig. 6). The
absence of significant changes in the level of caspase-9 involved in
the intrinsic apoptotic pathway agrees with a large increase in the
level of HSP27 protein, which is known to inhibit the apoptosome
assembly and caspase-9 activation [17]. The levels of HSP70 and
HSP 90, also capable of regulating the apoptosome, did not
change in HSAECs infected with RVFV.
Further evidence in favor of the intrinsic apoptotic pathway
inhibition by the infection was revealed by the behavior of the
proapoptotic mitochondrial proteins of Bcl-2 family, namely: the
Bcl-2-associated protein X (Bax); the p53-upregulated modulator
of apoptosis (Puma); the pro-apoptotic (Bim); the Bcl-2-interacting
domain (Bid); and Bad. The latter inhibits anti-apoptotic protein
Bcl-XL and induces apoptosis when it is phosphorylated on S136
by AKT. In RVFV-infected cells, Bad (S136) phosphorylation
demonstrated no substantial change until 72 h.p.i. The levels of
Bid and Bax did not change, however a decrease was observed for
Puma and Bim (Table 1). Collectively, these results are consistent
with upregulation of extrinsic apoptotic signaling in infected cells.
Figure 3. Total level of cellular proteins in RVFV-infected
HSAECs. Slides stained with Sypro Ruby and normalized relative to
uninfected HSAECs at 0 h.p.i. Each sample of 40 cells per dot along with
seven 26serial dilutions was printed in duplicate. Black and gray bars
illustrate the MOI of 0.002 and 0.0002, correspondingly. Data represent
mean values and confidence intervals of two-tail t-test (a=0.05, n=3).
doi:10.1371/journal.pone.0013805.g003
Figure 2. Example of RPMA slides stained with antibodies against total and phosphorylated forms of SAP/JNK, ERK and AKT and
against phosphorylated form of p-38 and PTEN. Portions of slides stained with antibodies against total and phosphorylated protein forms are
shown for untreated (Control) and RVFV-infected HSAECs at 48 and 72 h.p.i. Low and high MOI correspond to 0.0002 and 0.002, respectively. Each
sample along with eight 26serial dilutions was printed in duplicate. Prefixes t and p indicate the total and phosphorylated proteins, correspondingly.
doi:10.1371/journal.pone.0013805.g002
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signaling
MAPK (JNK, p38, ERK) pathways constitute a large kinase
network that regulates a variety of physiological processes, such as
cell growth, differentiation, and apoptotic cell death in response to
different stimuli. We found that during RVFV infection in
HSAECs the normalized levels of phosphorylation of MAPKs,
including p38, JNK and ERK, were upregulated and followed
specific patterns of changes (Table 1 and Fig. 5). As mentioned
above, phosphorylation of ERK on T202/Y204 was steadily
increased, although the total amount of ERK was relatively stable
and even showed a tendency to decline at 72 h.p.i. in comparison
with uninfected cells (Table 1 and Fig. 4, 5). In order to confirm
activation of the ERK pathway, we tested the phosphorylation of
MEK1/2 upstream of ERK1/2 with Western blotting (Fig. 4). As
Table 1. Signaling protein levels in RVFV-infected HSAECs.
Protein 48 h.p.i. 72 h.p.i.
Control Low High Control Low High
M
1 CI
2 MC IMC I MC IM C IM C I
Group I
p-ERK 1.0 0.3 1.3 0.3 2.0 0.3 1.0 0.3 3.0 0.4 3.0 0.5
p-STAT1 1.0 0.3 1.6 0.1 4.0 0.3 1.0 0.2 4.9 0.5 4.7 0.6
Caspase 3 cleaved 1.0 0.4 1.3 0.1 1.9 0.4 1.0 0.2 3.3 0.2 3.5 0.3
Caspase 6 cleaved 1.0 0.1 1.1 0.0 1.9 0.2 1.0 0.1 2.6 0.1 3.0 0.3
Caspase 7 cleaved 1.0 0.1 1.2 0.1 1.8 0.4 1.0 0.0 3.0 0.2 2.9 0.1
p53 S15 1.0 0.1 2.5 0.2 5.6 0.3 1.0 0.2 8.6 1.1 5.6 0.5
p70S6 T412 1.0 0.1 1.2 0.1 1.5 0.1 1.0 0.0 1.8 0.3 1.3 0.1
Src Y416 1.0 0.1 1.0 0.1 1.2 0.1 1.0 0.1 1.2 0.1 1.4 0.1
Group II
P53 S46 1.0 0.0 6.2 0.1 32 0.4 1.0 0.2 25 0.1 5.9 0.1
JNK T183/185 1.0 0.3 3.3 0.3 9.5 1.4 1.0 0.1 6.4 0.9 2.3 0.3
p90RSK S380 1.0 0.3 2.0 0.2 4.2 0.8 1.0 0.2 4.7 0.3 2.9 0.3
HSP27 1.0 0.1 2.1 0.3 4.5 0.5 1.0 0.2 2.3 0.1 1.8 0.2
MSK1 S360 1.0 0.4 2.0 0.2 3.6 2.2 1.0 0.7 1.6 1.2 1.5 0.5
p38 T180 1.0 0.2 1.9 0.2 3.8 0.2 1.0 0.2 3.8 0.3 2.2 0.4
MEK1/2 1.0 0.0 1.8 0.0 2.9 0.1 1.0 0.2 3.3 0.1 1.4 0.1
STAT3 S727 1.0 0.2 1.3 0.2 1.5 0.2 1.0 0.0 1.1 0.1 0.8 0.1
ATF2 T69/71 1.0 0.5 1.4 0.5 2.4 0.8 1.0 0.2 1.3 0.8 1.0 1.1
NF-kB S536 1.0 0.0 1.8 0.1 2.7 0.3 1.0 0.1 1.1 0.4 0.6 0.1
CREB S133 1.0 0.5 1.3 0.3 2.0 0.3 1.0 0.4 2.8 0.5 1.3 0.7
IRS S612 1.0 0.0 1.3 0.0 1.8 0.0 1.0 0.0 1.4 0.2 0.8 0.0
Src Y527 1.0 0.1 1.4 0.0 1.1 0.1 1.0 0.0 0.8 0.0 0.5 0.1
Group III
AKT S473 1.0 0.1 1.1 0.1 0.8 0.1 1.0 0.2 0.6 0.2 0.5 0.2
XIAP 1.0 0.1 1.0 0.1 0.9 0.1 1.0 0.1 0.7 0.1 0.5 0.1
Bim 1.0 0.1 1.0 0.0 0.6 0.2 1.0 0.1 0.5 0.1 0.3 0.1
Puma 1.0 0.1 0.9 0.2 0.5 0.1 1.0 0.1 0.6 0.0 0.3 0.1
LC3b 1.0 0.2 1.0 0.1 0.9 0.1 1.0 0.1 0.8 0.2 0.5 0.2
PKR T451 1.0 0.1 1.1 0.1 0.9 0.1 1.0 0.1 0.8 0.1 0.6 0.1
FOX T24/31 1.0 0.1 1.0 0.0 0.9 0.0 1.0 0.0 0.8 0.0 0.8 0.1
Total protein levels
ERK total 1.0 0.0 1.2 0.1 1.5 0.1 1.0 0.1 1.0 0.3 1.4 0.2
38 total 1.0 0.2 1.3 0.2 1.2 0.3 1.0 0.1 1.0 0.2 0.7 0.1
JNK total 1.0 0.2 1.2 0.2 1.1 0.1 1.0 0.0 1.2 0.1 1.0 0.1
AKT total 1.0 0.0 1.2 0.1 1.5 0.1 1.0 0.1 1.0 0.3 1.4 0.2
Actin 1.0 0.1 1.0 0.1 1.0 0.1 1.0 0.1 1.2 0.1 1.2 0.1
1Arithmetic mean.
2Confidence interval, Student’s two-tail test, a=0.05. RPMA data represent 3 independent experiments carried out in duplicate. The values are shown relative to the
untreated HSAECs after normalization to the total cellular protein content at each time point.
doi:10.1371/journal.pone.0013805.t001
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24 h.p.i. preceded activation of ERK, which took place at 48 h.p.i.
(MOI of 0.002). Downstream from activated ERK1/2 the survival
signaling was propagated to p90RSK (Group II in Table 1). This
kinase can activate the transcription factor CREB, which
promotes cell survival through transcriptional up-regulation of
anti-apoptotic Bcl-2, Bcl-XL, and Bcl-1 proteins. Increased CREB
phosphorylation on S133 was observed, in agreement with
phosphorylation of p90RSK (Group II in Table 1).
JNK1/2 (c-Jun N-terminal kinase 1/2) pathway activity can
mediate apoptosis,proliferation,orsurvival,depending onthe stimuli
and cellular conditions. Interestingly, sustained JNK1/2 activity is
necessary for cellular homeostasis, whereas strong stress stimuli in
non-transformed cells lead primarily to JNK-mediated apoptosis
[18,19]. Total amount of JNK1/2 did not change in comparison to
untreated cells (Table 1, Fig. 4). Activated form of JNK1/2
phosphorylated on T183/T185 increased in infected HSAECs at
48 h.p.i. for both MOIs. This increase was followed by a strong
Figure 4. Confirmation of RPMA data by Western blot using antibodies against phosphorylated and total forms of several proteins.
Western blots were performed on twoindependent experiments. TheRVFV-infectedHSAECs with MOI of 0.002and0.0002 atcorrespondingtime points
are indicated with a + sign. Samples 1, 2, 4, 6, 8 and 11 are from untreated cells at 0, 5, 24, 30, 48 and 72 h.p.i. and samples 3, 5, 7, 10 and 13 are RVFV-
infected HSAECs with MOI of 0.002 at 5, 24, 30, 48 and 72 h.p.i. Samples 9 and 12 correspond to the cells infected with MOI of 0.0002 at 48 and 72 h.p.i.
doi:10.1371/journal.pone.0013805.g004
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continued to increase at MOI of 0.0002 (Table 1 and Fig. 4, 5).
The p38 MAPK pathway can be activated in response to a
plethora of inflammatory cytokines, as well as pathogens and by
environmental stress, such as osmotic stress, ultraviolet light, heat
shock, and hypoxia. The activation of the p38 MAPK pathway is
required for apoptosis induction in several different cellular models
[20–23]. Additionally, stress-elicited p38 activation was shown to
cause G2/M cell cycle arrest and to regulate the cell cycle through
modulation of p53 and p73 tumor suppressor proteins [24,25].
Similar to the proteins from Group II (Table 1, Fig. 4, 5), RVFV
infection in HSAECs stimulated phosphorylation of p38 on T180.
The activation pattern of MAPKs prompted us to analyze the
phosphorylation of transcriptional factors as their most important
Figure 5. Comparison of RPMA and Western blot data. Left panels (A) show the RPMA data. Right panels (B) show Western blot confirmatory
data. X axis labels, time post infection (h.p.i.); Y axis labels, protein level relative to untreated cells (%) at 0 h.p.i. Open triangles, closed triangles and
open squares correspond to the low MOI, high MOI and uninfected cells, respectively. RPMA data represent mean values and confidence intervals of
two-tail t-test (a=0.05, n=3). Western blot data represent average of two independent experiments.
doi:10.1371/journal.pone.0013805.g005
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STAT1 (Y701), ATF2 (T69/71), MSK (S360), CREB (S133), NF-
kB (S536), and p53 (S15/46) infection were transiently increased
in general agreement with activation of MAPKs’ phosphorylation
(Table 1 and Fig. 4, 5).
Downregulation of pro-survival signaling through
decreased phosphorylation of pro-survival AKT and anti-
apoptotic XIAP
The PI3K-AKT network activated by cytokines or growth
factors mediates intracellular signals to regulate a variety of
cellular responses, including anti-apoptosis, proliferation, cell
cycling, protein synthesis, glucose metabolism and telomere
activity [27–29]. RVFV infection decreased the phosphorylation
of AKT on its major activation site S473 without considerable
changes in the total amount of AKT in comparison with
uninfected cells (Table 1 and Fig. 4). In agreement with this, the
inhibitor of apoptosis, XIAP100 [30–33], was decreased in the
infected cells, further contributing to apoptosis. Our data also
show that RVFV infection downregulated the level of LC3B which
is involved in cell autophagy.
Effect of p38, JNK and MEK1/2 inhibitors on RVFV
replication
Our results indicated that MAPK pathways regulating cell fate
in response to different stimuli were activated during RVFV
infection. Therefore, we were interested in determining if
inhibitors of these pathways could affect RVFV replication. For
this purpose, we chose to test the inhibitors of p38 (SB203580),
JNK (JNK Inhibitor II) and ERK1/2 (MEK1/2 Inhibitor III) in
cells infected with RVFV MP-12. In preliminary experiments we
showed that the MP-12 strain induced ERK1/2, p38, and JNK
phosphorylation in a manner similar to ZH-501 (Fig. S1). We also
found that in agreement with the ZH-501 data, the MP-12-
infected cells demonstrated the onset of apoptosis evident in the
increased degradation of cellular DNA. Figure S2 shows
Figure 6. RPMA data for caspase-3, -6, -7, and -9 and actin. X axis labels, time post infection (h.p.i); Y axis labels, protein level relative to
untreated cells (%) at 0 h.p.i. Open triangles, closed triangles and open squares correspond to the low MOI, high MOI and uninfected cells,
respectively. Data represent mean values and confidence intervals of two-tail t-test (a=0.05, n=3).
doi:10.1371/journal.pone.0013805.g006
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characteristic of cell death during the course of infection.
HSAECs pretreated with the inhibitors for 5 h were infected
with RVFV MP-12 at MOI 0.002. Supernatants were collected at
48 h.p.i. and analyzed by q-RT-PCR to determine the influence of
these inhibitors on viral replication. We found that the cells treated
with SB203580 demonstrated increased viral release (p=0.0002)
compared to the untreated cells (Fig. 7). The inhibitor of JNK did
not show a statistically reliable change, indicating that JNK
pathway might not control viral replication. However, the MEK1/
2 inhibitor selectively affecting phosphorylation of the downstream
ERK1/2 decreased viral titer (p=0.031). No cell toxicity was
observed at the concentrations of inhibitors used, indicating that
the decrease in viral replication was not due to cell death (data not
shown). These results suggested that p38 activity represents the
protective cell response while activation of ERK1/2 pathway
contributes to viral replication. Mechanisms of these effects are a
subject of ongoing investigation.
Discussion
Host cell signaling is considered as one of the targets for future
antiviral therapies. However, very little information is currently
available regarding the RVFV infection in susceptible cells
relevant to inhalation exposure. We chose experimental conditions
with low MOI, likely reflecting the low-dose exposure to the virus
in the natural environment, and found the lung epithelial cells to
be highly susceptible. The cytopathic changes in the cells exposed
to virulent strain ZH-501 took place over the period of 72 h,
which allowed us to monitor a gradual development of infection,
with the focus to identify the major pathways involved in the
regulation of cell death.
In our study for the first time we undertook quantitative analysis
of phosphoprotein signaling induced by RVFV in HSAECs using
RPMA. This approach allowed us to analyze at the same time the
changes in the levels of phospho-modifications, activated forms, or
total levels for 60 proteins. The signaling pathways altered in
HSAECs infected with RVFV are summarized in Fig. 8.
Significant changes in PI3K-AKT, MAPK, apoptotic and p53
pathways were observed. The AKT pathway is known to be one of
the prominent anti-apoptotic programs in mammalian cells that
leads to inactivation of numerous apoptotic stimuli [27–29]. PI3K-
Akt pathway is an important mechanism through which viral
infection influences various cell functions. Activating PI3K-AKT
signaling can slow down apoptosis and prolong viral replication in
both acute and persistent infection [reviewed in ref. 34].
Accumulating evidence suggests that the activity of PI3K or
AKT is critical for survival of several viruses. Adenovirus relies on
PI3K-mediated organization of actin filament for active internal-
ization. Non-segmented negative-sense RNA viruses require AKT
to enhance synthesis of viral RNAs. On the other hand, PI3K-
AKT signaling is associated with up-regulating interferon
response. Higher PI3K-AKT activity might impede viral propa-
gation due to activation of cellular defenses. Influenza A virus
requires active PI3K for penetration despite the negative effects of
inducing immune response. Unlike most viruses, it was reported
that VP1 protein of foot-and-mouth disease virus inhibits AKT to
promote cell death [reviewed in ref. 34] RVFV inhibition of AKT
phosphorylation in HSAECs can promote cell death. Identifica-
tion of virus protein(s) inducing this anti-survival signaling may
provide clues to virus pathogenicity.
The conserved inhibitor of apoptosis (IAP) family plays an
important role in regulation of apoptosis through modulation of
caspases [32,33]. IAPs can bind directly to caspases, leading to
either their inactivation or degradation. The most potent caspase
inhibitor of the IAP family is X-linked IAP, XIAP [33,35]. In the
RVFV-infected HSAECs, AKT and XIAP downregulation as well
as the caspase upregulation are progressively increased and
therefore likely predispose cells to apoptosis.
Caspases -3, -6 and -7 are effector caspases for both the intrinsic
and extrinsic apoptotic pathways. To distinguish between these
apoptotic pathways we analyzed proteins upstream of effector
caspases. The cysteine aspartyl protease caspase-9 plays a central
role in the mitochondrial or intrinsic apoptotic pathway that is
engaged in response to many apoptotic stimuli. Caspase-9 is
activated in a large multimeric complex, the apoptosome, which is
formed with apoptotic peptidase activating factor 1 (Apaf1) in
response to the release of cytochrome C from mitochondria [36].
Cleavage of caspase-9 on two sides Asp315 and Asp330 are
necessary for there activation. Once activated, caspase-9 cleaves
and activates the effector caspases 3 and 7 to bring about apoptosis.
This pathway is tightly regulated at multiple steps, including
apoptosome and cleaved caspase-9 formation. We detected no
statistically significant changes in the level of cleaved caspase-9
between uninfected and RVFV-infected HSAECs. Therefore
activation of caspases -3 and -7 most likely took place through the
extrinsic pathway. Increased level of HSP27 is consistent with this
conclusion [30]. In this respect, manipulation with caspases is not
unique to RVFV. Influenza virus was reported to induce apoptosis
by extrinsic death signaling through Fas/Fas-associated death
domain-containing protein (FADD)/caspase-8 pathway [37]. The
level of cellular caspase-3 activity correlated directly with the
amount of progeny virus produced in the host cell line infected with
influenza virus [38]. Similarly, the inhibition of caspases 3 and 9
with synthetic inhibitors, along with reducing apoptosis, reduced
infective adenovirus titer in a dose-dependent manner [39].
p53 acts predominantly as a transcription factor, regulating the
expression of more then 100 target genes to initiate apoptosis, cell
cycle arrest, DNA repair, cellular senescence as well as
differentiation [40]. RVFV induced the increase in phosphoryla-
tion of p53 on both apoptosis-related sides, on S15 and S46.
However, our data do not show increased levels of apoptotic
proteins transcriptionally regulated by p53 (Bax, Bad, Bim, Puma,
and Bid). This indicates that RVFV might possess other
Figure 7. Effect of inhibitors on RVFV replication. HSAECS were
plated at 5610
4 cells per well in a 96-well plate and pretreated with
either DMSO or indicated inhibitors for 5 h prior to RVFV infection at
MOI of 0.002 as described in Materials and Methods. Following
infection, fresh medium containing inhibitors was added. Supernatants
were collected at 48 h.p.i., viral RNA extracted and analyzed by q-RT-
PCR. *p=0.0002, ** p=0.031 (t-test) relative to mock control.
doi:10.1371/journal.pone.0013805.g007
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pathway, such as the NSm-dependent one [8], in addition to the
upregulation of HSP27 discussed above.
Members of the MAPK family are involved in signal
transduction of apoptosis as well as cell growth and differentiation.
During RVFV ZH-501 infection in HSAECs the phosphorylations
of MAPKs including p38, JNK and ERK were found to be
upregulated. ERK1/2 plays a central role in cell proliferation and
differentiation [41–43]. At both MOIs, constant progression of
ERK1/2 activation took place in HSAECs infected with RVFV in
agreement with the increased phosphorylation on S380 of the
upstream ERK1/2-activating kinase p90RSK. Activation of
p90RSK was also evident in the increased phosphorylation of
the downstream CREB. This pattern was consistent with a pro-
survival host response through ERK1/2, although it did not
exclude the role of the ERK signaling cascade in promoting
RVFV replication, as it has been shown for influenza virus [44].
The JNK pathway is activated by cellular stress and by cytokine
induction. JNK pathway activity can mediate apoptosis, prolifer-
ation, or survival, depending on the stimuli and cellular conditions.
Sustained JNK activity is necessary for cellular homeostasis,
whereas strong stress stimuli in non-transformed cells primarily
lead to JNK-mediated apoptosis. The activated form of JNK
phosphorylated on T183 and Y185 was increased in RVFV-
infected HSAECs initially and then dramatic dephosphorylation
was observed (more then 10-fold at 72 h.p.i. in comparison with
48 h.p.i) by the higher dose of infection, indicating that it is one of
the major RVFV targets.
Figure 8. RPMA data presented as a diagram of signaling events in HSAECs infected with RVFV. Among the most prominent responses
was activation of MAP kinases (p38, JNK and ERK) and the downstream transcriptional factors [STAT1 (Y701), ATF2 (T69–71), MSK1 (S360), and CREB
(S133)]. STAT3 and NF-kB phosphorylation were also increased. Activation of p53(S15, S46), which typically accompanies transcriptional upregulation
of the apoptotic genes correlated with the increased levels of cleaved effector caspase-3, -6 and -7 indicating activation of the extrinsic apoptotic
pathway. RVFV infection also downregulated phosphorylation of a major anti-apoptotic regulator of survival pathways, AKT (S473). Consistent with
this, the level of apoptosis inhibitor XIAP100 was decreased. The intrinsic apoptotic pathway marker, caspase-9, demonstrated only a marginal
activation accompanied by increased level of the inhibitor of apoptosome formation, HSP27.
doi:10.1371/journal.pone.0013805.g008
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induction in several different cellular models [20–23]. Addition-
ally, stress-elicited p38 activation was shown to cause G2/M cell
cycle arrest and to regulate the cell cycle through modulation of
p53 and p73 tumor suppressor proteins [24] RVFV infection in
HSAECs demonstrates similar patterns of phosphorylation for p38
and JNK for both of these pathways important for cell survival.
Phosphorylated p38 proteins can activate an array of transcription
factors, including ATF2, CHOP1, MEF2, p53, STAT1 and Elk1.
For JNK a classical substrate is the transcription factor c-Jun along
with ATF2, Elk1, MEF2c, p53, STAT1, and c-Myc. Our data for
STAT1 (Y701), ATF2 (T69–71) and MSK1 (S360) indicate their
coordinated upregulation with MAPKs and implicate RVFV in a
widespread control of cellular transcription.
Taking into account the importance of MAPK pathways for cell
fate we tested the effect of p38, JNK and ERK1/2 phosphory-
lation inhibitors on replication of RVFV MP-12 strain, which
demonstrated activation of MAPKs similar to ZH-501. Using the
inhibitor-pretreated cells, we found that viral growth can be
promoted or inhibited by the p38 and ERK1/2 pathway
inhibitors, correspondingly, while JNK cascade did not exert a
strong effect on the amount of released virus. These data support a
potential utility of phosphoprotein signaling cascades as host
targets for treatment of viral infections. However, a strong
influence of MOI on the level and dynamics of transient cell
responses (Table 1) brings up an additional level of complexity,
which needs to be addressed in future studies. For example,
phosphorylation of several proteins from group II at certain time
demonstrated either increasing or decreasing trends, depending on
the progress of infection. We therefore suggest that potential
signaling-based therapeutic interventions would need to take into
account not only the nature but also a magnitude of the particular
response for adequate treatment. Future experiments with specific
inhibitors administered at different times post infection will help
understand the significance of the identified pathways for survival/
death cell decision in RVFV-infected HSAECs. The experiments
with aerosol RVFV-infected animals are also forthcoming to
analyze virus-induced signaling in the lung and to reconcile these
findings with our in vitro model.
Supporting Information
Figure S1 Induction of ERK1/2, p38, and JNK by RVFV MP-
12. Western blots were performed on lysates of RVFV MP-12-
infected HSAECs at indicated times post infection with MOI of
0.002 (for ERK1/2, p38 and JNK). Open and grey bars show
band intensities of uninfected and infected cells, correspondingly,
calculated relative to uninfected cells at 24 h.p.i.
Found at: doi:10.1371/journal.pone.0013805.s001 (0.92 MB TIF)
Figure S2 Sub-G1 cell cycle fraction of HSAECs is increased
during RVFV infection. HSAECs were mock infected or infected
with RVFV MP12 at MOI of 3.0. Cells were collected at 6, 24,
and 48 h.p.i. and cell cycle analysis performed by propidium
iodide staining. Flow cytometry data were acquired on a Becton
Dickinson FACScaliber with a 488-nm argon laser. Acquisition
and analysis were performed with CELLQuest software. A. The
percent of the sub-G1 population relative to the total number of
cells as average of two independent samples. Open bars, mock-
infected cells; gray bars, RVFV-infected cells. B. Histogram of the
sample at 48 h.p.i. illustrating the position of the sub-G1 fraction
gate.
Found at: doi:10.1371/journal.pone.0013805.s002 (0.71 MB TIF)
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